Roberto Torres
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Advanced Breast Cancer Therapies
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 9
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Guy Jérusalem (6 shared papers)Kelly Pendergrass (6 shared papers)Didier Verhoeven (6 shared papers)Angelo Di Leo (6 shared papers)Miguel Martín (7 shared papers)Luboš Petruželka (5 shared papers)Sally Garnett (5 shared papers)Р. Ш. Хасанов (5 shared papers)
In The Last Decade
Roberto Torres
19 papers receiving 805 citations
Roberto Torres's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 416
- Pulmonary and Respiratory Medicine 450
- Cancer Research 196
- Genetics 250
- Molecular Biology 124
Countries citing papers authored by Roberto Torres
This map shows the geographic impact of Roberto Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Torres more than expected).
Fields of papers citing papers by Roberto Torres
This network shows the impact of papers produced by Roberto Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Torres. The network helps show where Roberto Torres may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Torres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2010 | 479 |
| 2 | 2013 | 249 | |
| 3 | 2012 | 17 | |
| 4 | 2013 | 17 | |
| 5 | 2009 | 16 | |
| 6 | 2016 | 12 | |
| 7 | 2018 | 10 | |
| 8 | 2010 | 9 | |
| 9 | 2021 | 7 | |
| 10 | 2006 | 5 | |
| 11 | 2013 | 3 | |
| 12 | 2006 | 3 | |
| 13 | 2015 | 3 | |
| 14 | 2009 | 3 | |
| 15 | 2012 | 3 | |
| 16 | [Laparoscopic cholecystectomy. Report of the first 1300 cases carried out by a multidisciplinary team]. | 1996 | 3 |
| 17 | Communication Methods with Limited English Proficiency Research Participants to Acquire Informed Consent During Clinical Trials | 2014 | 2 |
| 18 | 2024 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 0 |
About Roberto Torres
Roberto Torres is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Surgery and Cancer Research, having authored 20 papers that have together received 844 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Estrogen and related hormone effects (5 papers), Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (3 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Testicular diseases and treatments (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Oncology (416 citations), Pulmonary and Respiratory Medicine (450 citations), Cancer Research (196 citations), Genetics (250 citations) and Molecular Biology (124 citations). Roberto Torres has collaborated with scholars based in Chile, Brazil and Spain. Frequent co-authors include Guy Jérusalem, Kelly Pendergrass, Didier Verhoeven, Angelo Di Leo, Miguel Martín, Luboš Petruželka, Sally Garnett, Р. Ш. Хасанов, Igor Bondarenko and José Luiz Pedrini. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, International Journal of Gynecological Cancer, Antiviral Therapy and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.